Jane Street’s Verona Pharma VRNA Stock Holding History

Jane Street’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-85,400	Closed	-$9.11M	–	12511
2025 Q3	$9.11M	Sell	85,400 -150,000	-64%	-$15.7M	﹤0.01%	2544
2025 Q2	$22.3M	Buy	235,400 +87,600	+59%	+$6.49M	﹤0.01%	1350
2025 Q1	$9.38M	Buy	147,800 +63,100	+74%	+$3.77M	﹤0.01%	2072
2024 Q4	$3.93M	Buy	84,700 +47,000	+125%	+$1.76M	﹤0.01%	3017
2024 Q3	$1.08M	Sell	37,700 -38,400	-50%	-$945K	﹤0.01%	5718
2024 Q2	$1.1M	Buy	+76,100	New	+$1.11M	﹤0.01%	5583
2023 Q2	–	Sell	-46,300	Closed	-$930K	–	9647
2023 Q1	$930K	Sell	46,300 -39,600	-46%	-$855K	﹤0.01%	5132
2022 Q4	$2.24M	Buy	+85,900	New	+$1.14M	﹤0.01%	3687

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Jane Street's VRNA Position: Q4 2025 in Review

Jane Street sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 67,828 shares — an estimated $7.24M sold.

Jane Street first reported a position in VRNA in Q2 2017 and held it in 11 quarters. The position peaked at $16.1M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Jane Street reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Jane Street sold 67,828 Verona Pharma shares in Q4 2025, an estimated $7.24M.
Jane Street first reported a position in Verona Pharma in Q2 2017 and held it in 11 quarters.
Jane Street's Verona Pharma position peaked at $16.1M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.